Press Releases

Webcast
Q4 2017 Geron Earnings Conference Call
Mar 19, 2018 at 8:30 AM EDT
Webcast Presentation

Q4 2017 Geron Earnings Conference Call
Mar 19, 2018 at 8:30 AM EDT
Webcast
Geron at 17th Annual Needham Healthcare Conference
Mar 27, 2018 at 4:00 PM EDT
Webcast Presentation

Geron at 17th Annual Needham Healthcare Conference
Mar 27, 2018 at 4:00 PM EDT
Date Title and Summary  
Toggle Summary Geron Corporation Reports First Quarter 2017 Financial Results and Recent Events
MENLO PARK, Calif. , May 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2017 and recent events. First Quarter 2017 Results For the first quarter of 2017, the company reported operating revenues of $537,000 and
Toggle Summary Geron 2017 Annual Meeting of Stockholders to be Held on May 9
First Quarter 2017 Financial Results Expected Same Day MENLO PARK, Calif. , April 25, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will hold its 2017 Annual Meeting of Stockholders, on Tuesday, May 9, 2017 , at 4:00 p.m. PDT . Geron’s stockholders are invited to attend the Annual
Toggle Summary Geron Announces Completion of Second Internal Data Reviews for Imetelstat Trials Being Conducted by Janssen
Both IMerge and IMbark Continue in Lower Risk Myelodysplastic Syndromes and Relapsed or Refractory Myelofibrosis Conference Call Scheduled for 8:00 a.m. EDT Today, April 10 MENLO PARK, Calif. , April 10, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that Janssen Research
Toggle Summary Geron Announces Conference Call on April 10 at 8:00 A.M. Eastern Time
MENLO PARK, Calif. , April 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will host a conference call on April 10, 2017 , at 8:00 a.m. Eastern Time to provide an update on the ongoing imetelstat Phase 2/3 trial in myelodysplastic syndromes and the Phase 2 trial in myelofibrosis.
Toggle Summary Geron Reports Imetelstat Presentation at American Association for Cancer Research Annual Meeting
MENLO PARK, Calif. , April 05, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced a poster presentation by Janssen Research & Development, LLC describing non-clinical data on the telomerase inhibitor imetelstat at the 2017 American Association for Cancer Research (AACR) Annual
Toggle Summary Geron Announces Presentation at American Association for Cancer Research Annual Meeting
MENLO PARK, Calif. , March 02, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced an abstract submitted by Janssen Research & Development, LLC describing non-clinical data on imetelstat has been accepted for presentation as a poster at the 2017 American Association for Cancer
Toggle Summary Geron Corporation Reports Fourth Quarter and Annual 2016 Financial Results
Conference Call Scheduled for 4:30 p.m. ET Today, March 1 MENLO PARK, Calif. , March 01, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the fourth quarter and year ended December 31, 2016 and recent events.
Toggle Summary Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2016 Financial Results
MENLO PARK, Calif. , Feb. 22, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the fourth quarter and year ended December 31, 2016 , on Wednesday, March 1, 2017 , after the market close. Geron’s management will also host a conference call for analysts
Toggle Summary Geron Reports Imetelstat Presentations at American Society of Hematology Annual Meeting
MENLO PARK, Calif. , Dec. 06, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced four presentations of exploratory preclinical and clinical data related to the imetelstat program at the 58th American Society of Hematology (ASH) Annual Meeting and Exposition held in San Diego,
Toggle Summary Geron Announces November Investor Conference Presentation Webcasts
MENLO PARK, Calif. , Nov. 07, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett , M.D., President and Chief Executive Officer, is scheduled to present at the following investor conferences: Stifel 2016 Healthcare Conference in New York at 9:30 a.m.